Cargando…

Prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings

BACKGROUND: The prognosis of patients with lung cancer who demonstrate pleural plaques intraoperatively, which may be associated with exposure to asbestos, is unclear. Here, we compared the clinicopathological characteristics and prognosis of these patients to those of patients without pleural plaqu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kagimoto, Atsushi, Mimura, Takeshi, Kamigaichi, Atsushi, Yamashita, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052480/
https://www.ncbi.nlm.nih.gov/pubmed/35484615
http://dx.doi.org/10.1186/s12885-022-09600-6
_version_ 1784696792115314688
author Kagimoto, Atsushi
Mimura, Takeshi
Kamigaichi, Atsushi
Yamashita, Yoshinori
author_facet Kagimoto, Atsushi
Mimura, Takeshi
Kamigaichi, Atsushi
Yamashita, Yoshinori
author_sort Kagimoto, Atsushi
collection PubMed
description BACKGROUND: The prognosis of patients with lung cancer who demonstrate pleural plaques intraoperatively, which may be associated with exposure to asbestos, is unclear. Here, we compared the clinicopathological characteristics and prognosis of these patients to those of patients without pleural plaques. METHODS: We included patients who underwent curative-intent resection for non-small cell lung cancer. We retrospectively investigated the relationship of intrathoracic findings of pleural plaques with clinicopathological features and prognosis. RESULTS: Pleural plaques were found in 121/701 patients (17.3%) during surgery. The incidence of squamous cell carcinoma (P < 0.001) and the pathological stage (P = 0.021) were higher in patients with pleural plaques. Overall survival was significantly worse in patients with pleural plaques (5-year rate; 64.5% vs. 79.3%; P < 0.001), and the same finding was noted in clinical stage I patients (5-year rate; 64.8% vs. 83.4%; P < 0.001). In multivariable analysis, the presence of pleural plaques was a significant predictor of overall survival in patients with clinical stage I (hazard ratio, 1.643; P = 0.036). In the analysis among patients with emphysema more severe than Goddard score 5 points or interstitial pneumonia, overall survival was significantly worse in those with pleural plaques than in those without pleural plaques (5-year rate; 66.3% vs. 49.5%; P < 0.001). CONCLUSIONS: Patients with non-small cell lung cancer who underwent resection and demonstrated pleural plaques intraoperatively had a significantly worse prognosis. It is important to recognize the presence of pleural plaques intraoperatively, and our findings will be useful in determining the treatment and follow-up strategy for such patients with lung cancer and pleural plaques on intrathoracic examination. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09600-6.
format Online
Article
Text
id pubmed-9052480
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90524802022-04-30 Prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings Kagimoto, Atsushi Mimura, Takeshi Kamigaichi, Atsushi Yamashita, Yoshinori BMC Cancer Research BACKGROUND: The prognosis of patients with lung cancer who demonstrate pleural plaques intraoperatively, which may be associated with exposure to asbestos, is unclear. Here, we compared the clinicopathological characteristics and prognosis of these patients to those of patients without pleural plaques. METHODS: We included patients who underwent curative-intent resection for non-small cell lung cancer. We retrospectively investigated the relationship of intrathoracic findings of pleural plaques with clinicopathological features and prognosis. RESULTS: Pleural plaques were found in 121/701 patients (17.3%) during surgery. The incidence of squamous cell carcinoma (P < 0.001) and the pathological stage (P = 0.021) were higher in patients with pleural plaques. Overall survival was significantly worse in patients with pleural plaques (5-year rate; 64.5% vs. 79.3%; P < 0.001), and the same finding was noted in clinical stage I patients (5-year rate; 64.8% vs. 83.4%; P < 0.001). In multivariable analysis, the presence of pleural plaques was a significant predictor of overall survival in patients with clinical stage I (hazard ratio, 1.643; P = 0.036). In the analysis among patients with emphysema more severe than Goddard score 5 points or interstitial pneumonia, overall survival was significantly worse in those with pleural plaques than in those without pleural plaques (5-year rate; 66.3% vs. 49.5%; P < 0.001). CONCLUSIONS: Patients with non-small cell lung cancer who underwent resection and demonstrated pleural plaques intraoperatively had a significantly worse prognosis. It is important to recognize the presence of pleural plaques intraoperatively, and our findings will be useful in determining the treatment and follow-up strategy for such patients with lung cancer and pleural plaques on intrathoracic examination. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09600-6. BioMed Central 2022-04-28 /pmc/articles/PMC9052480/ /pubmed/35484615 http://dx.doi.org/10.1186/s12885-022-09600-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kagimoto, Atsushi
Mimura, Takeshi
Kamigaichi, Atsushi
Yamashita, Yoshinori
Prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings
title Prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings
title_full Prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings
title_fullStr Prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings
title_full_unstemmed Prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings
title_short Prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings
title_sort prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052480/
https://www.ncbi.nlm.nih.gov/pubmed/35484615
http://dx.doi.org/10.1186/s12885-022-09600-6
work_keys_str_mv AT kagimotoatsushi prognosisofresectednonsmallcelllungcancerwithpleuralplaquesonintrathoracicfindings
AT mimuratakeshi prognosisofresectednonsmallcelllungcancerwithpleuralplaquesonintrathoracicfindings
AT kamigaichiatsushi prognosisofresectednonsmallcelllungcancerwithpleuralplaquesonintrathoracicfindings
AT yamashitayoshinori prognosisofresectednonsmallcelllungcancerwithpleuralplaquesonintrathoracicfindings